SCHEMBL9733934

SCHEMBL9733934

O=C(O)CCC(=O)c1ccc(O)cc1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.45
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 3/20 0.44
MAPK1 P28482 1/20 0.44
HIF1A Q16665 1/20 0.44
HTT P42858 2/20 0.44
ERCC5 P28715 2/20 0.44
FEN1 P39748 2/20 0.44
HSD17B10 Q99714 2/20 0.42
KDM4E B2RXH2 1/20 0.41
CYP1A2 P05177 1/20 0.41
GLA P06280 1/20 0.41
POLB P06746 1/20 0.41
CYP2D6 P10635 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 1/20 0.41
MAPT P10636 1/20 0.41
CASP3 P42574 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL481408 0.84 ALDH1A1 (0.65) KMT2AMEN1ALDH1A1MAPK1HIF1A
SCHEMBL11195785 0.82 HTT (0.54) KMT2AMEN1ALDH1A1MAPK1HIF1A
SCHEMBL1134290 0.81 HTT (0.62) KMT2AMEN1ALDH1A1MAPK1HTT
SCHEMBL16432142 0.79 ALDH1A1 (0.69) ALDH1A1MAPK1HIF1AERCC5FEN1
SCHEMBL8019351 0.79 HTT (0.64) KMT2AMEN1ALDH1A1MAPK1HTT
SCHEMBL6579360 0.78 PTPN1 (0.48) ALDH1A1MAPK1HIF1AERCC5FEN1
SCHEMBL27520109 0.78 HSP90AB1 (0.67) KMT2AMEN1ALDH1A1MAPK1HIF1A
SCHEMBL945711 0.77 TSHR (0.65) KMT2AMEN1ALDH1A1HTTHSD17B10
SCHEMBL29567497 0.77 TSHR (0.65) KMT2AMEN1ALDH1A1HTTHSD17B10
SCHEMBL10576213 0.76 ERCC5 (0.59) KMT2AMEN1ALDH1A1MAPK1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5135940-A Antiallegens, antiinflammatory agents MERCK FROSST CANADA, INC. (CA) 1992-08-04 US disclosed
EP-0252639-A1 Leukotriene antagonists MERCK FROSST CANADA INC. (CA) 1988-01-13 EP disclosed
EP-0104885-B1 LEUKOTRIENE ANTAGONISTS, THEIR PRODUCTION, AND COMPOSITIONS CONTAINING THEM MERCK FROSST CANADA INC. (CA) 1986-06-04 EP disclosed
EP-0156233-A2 Use of leukotriene antagonists for producing cytoprotective pharmaceutical compositions and process for producing cytoprotective pharmaceutical compositions MERCK & CO. INC. (US) 1985-10-02 EP disclosed
EP-0104885-A1 Leukotriene antagonists, their production, and compositions containing them MERCK FROSST CANADA INC. (CA) 1984-04-04 EP disclosed